These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Preprints are manuscripts made publicly available before they have been submitted for formal peer review and publication. They might contain new research findings or data. Preprints can be a draft or final version of an author's research but must not have been accepted for publication at the time of submission.
Oligosaccharides such as the GalNAc-β-(1→4)-Gal disaccharide are involved in host-pathogen interactions and their synthesis is a continuing challenge for organic chemists. Only a few reports have discussed the synthesis of functionalized GalNAc-β-(1→4)-Gal for its further conjugation and applications in glycobiology. The synthetic route described here is taking advantage of (1) a simple and affordable GlcNAc donor which is epimerized to the more expensive GalNAc donor and (2) a 1,6-anhydro-galactose acceptor exalting the reactivity at the 4-position of galactose. The allyloxycarbonyl (Alloc) protecting group used at the 2-position of the GalNAc residue was important (1) for a successful epimerization of the GlcNAc residue into the corresponding GalNAc donor but also (2) for the stereoselective β-glycosylation through anchimeric assistance. The key disaccharide intermediate was further transformed to a trichloroacetimidate donor which could then be glycosylated with any alcohol. The example chosen here is the 3-azidopropyl aglycon for the design of multivalent glycoclusters.